Eli Lilly Stock News Today (Dec. 17, 2025): LLY Holds Near Record Highs as Analysts Lift Targets and Obesity Pipeline Momentum Builds
Eli Lilly and Company (NYSE: LLY) stock traded in the mid-$1,050s in U.S. session Wednesday, December 17, 2025, hovering near recent highs as investors weighed fresh analyst commentary and new partnership headlines against an already-strong run for the pharma giant. In early trading, LLY was modestly higher, with the session range spanning roughly $1,051 to $1,064. The near-term story for Eli Lilly stock remains dominated by one theme: sustained demand for its GLP-1/“incretin” portfolio (Mounjaro and Zepbound today, and a growing next-generation pipeline for tomorrow). But the market is also increasingly focused on what comes next—especially the oral obesity candidate